1. Wang K, He BY, Wang W, Niu HJ, Wang YR, Cai XJ*, Yang SX. Isolated neurosarcoidosis mimicking multifocal meningiomas: a diagnosis pitfall: A case report. Medicine. 95(46)(2016): e4994.
2. Chen MY, Lu C, Wang YF, Cai XJ*. Emphysematous cholecystitis in a young male without predisposing factors: A case report. Medicine. 95(44)(2016), e5367.
3. Ji T, Li GF, Chen J, Zhao J , Li X , Lin H, Cai XJ*, Cang Y. Distinct role of interleukin-6 and tumor necrosis factor receptor-1 in oval cell- mediated liver regeneration and inflammation-associated hepatocarcinogenesis. Oncotarget. 7(41)(2016), 66635-66646.
4. Chen J, Yu YJ, Ji T, Ma R, Chen MM, Li GF, Li FB, Ding Q, Kang QS, Huang DY, Liang X , Lin H, Cai XJ*. Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma. Cancer Med. 5(10)(2016), 2678-2687.
5. Zhou SJ, Shen JL, Lin S, Liu XL, Xu M, Shi L, Wang XF, Cai XJ*. Downregulated expression of DIXDC1 in hepatocellular carcinoma and its correlation with prognosis. Tumor Biology. 37(10)(2016), 13607-13616.
6. Xu JJ, Lin H, Li GH, Sun Y, Chen J, Shi L, Cai XJ*, Chang CS. The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals. EBioMedicine. 12(2016), 55-67.
7. Cai LX, Wei FQ, Yu YC, Cai XJ*. Can retrohepatic tunnel be quickly and easily established for laparoscopic liver hanging maneuver by Goldfinger dissector in laparoscopic right hepatectomy? J Zhejiang Univ Sci B. 17(9)(2016), 712-721.
8. Cai XJ*, Duan L, Wang YF, Jiang WB, Liang X, Yu H, Cai LX. Laparoscopic hepatectomy by curettage and aspiration: a report of 855 cases. Surg Endosc. 30(9)(2016), 4161.
9. Xu, JJ, Lin H, Li GH, Sun Y, Shi L, Ma WL, Chen J, Cai XJ*, Chang CS. Sorafenib with ASC-J9® synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signals. Int J Cancer. 2016.
10. Shen JL, Zhang YP, Yu H, Shen B, Liang YL, Jin RA, Liu XL, Shi L, Cai XJ*. Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy. Cancer Med. 5(8)(2016), 2061-2068.
11. Lin S, Zhou SJ, Jiang SJ, Liu XL, Wang YF, Zheng XY, Zhou HM, Li XH, Cai XJ*. NEK2 regulates stem-like properties and predicts poor prognosis in hepatocellular carcinoma. Oncol Rep. 36(2)(2016), 853-862.
12. Lai HC, Yeh CC, Jeng LB, Huang SF, Liao PY, Lei FJ, Cheng WC, Hsu CL, Cai XJ*, Chang C, Ma WL. Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells. Oncotarget. 7(29)(2016), 46448-46465.
13. Cai LX, Wei FQ, Yu YC, Yu H, Liang X, Cai XJ*. Laparoscopic Right Hepatectomy by the Caudal Approach Versus Conventional Approach: A Comparative Study. J Laparoendosc Adv Surg Tech A. 26(7)(2016), 540-547.
14. Feng YL, Xiang JF, Kong N, Cai XJ*, Xie AY. Buried territories: heterochromatic response to DNA double-strand breaks. Acta Biochim Biophys Sin. 48(7)(2016), 594-602.
15. Cai XJ*, Duan L, Wang YF, Jiang WB, Liang X, Cai LX. Laparoscopic hepatectomy by curettage and aspiration: a report of 855 cases. Surg Endosc. 30(7)(2016), 2904-2913
16. Zhao J, Chen J, Lin H, Jin RA, Liu JH, Liu XL, Meng N, Cai XJ*. The Clinicopathologic Significance of BAF250a (ARID1A) Expression in Hepatocellular Carcinoma. Pathol Oncol Res. 22(3)(2016), 453-459.
17. Shen JL, Lin H, Li GH, Jin RA, Shi L, Chen MM, Chang CS, Cai XJ*. TR4 nuclear receptor enhances the cisplatin chemo-sensitivity via altering the ATF3 expression to better suppress HCC cell growth. Oncotarget. 7(22)(2016), 32088-32099.
18. Ma L, Cai XJ*, Wang HH, Yu YL, Huang DY, Ge GJ, Hu HY, Yu SC. Laparoscopic colonic anastomosis using a degradable stent in a porcine model. World J Gastroenterol. 22(19)(2016), 4707-4715.
19. Tang JC, Feng YL, Guo T, Xie AY, Cai XJ*. Circulating tumor DNA in hepatocellular carcinoma: trends and challenges. Cell Biosci. 6(1)(2016), 32.
20. Wang JB, Sun HL, Gao L, Xie L, Cai XJ*. Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus: A clinical study of 73 patients. Head Neck. 38(2016), e1510-e1514.
21. Shi L, Lin H, Li GH, Jin RA, Xu JJ, Sun Y, Ma WL, Yeh SY, Cai XJ*, Chang CS. Targeting Androgen Receptor (AR)-> IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression. Mol Cancer Ther. 15(4)(2016), 731-742.
22. Lai C, Jin RA, Liang X, Cai XJ*. Comparison of laparoscopic hepatectomy, percutaneous radiofrequency ablation and open hepatectomy in the treatment of small hepatocellular carcinoma. J Zhejiang Univ Sci B. 17(3)(2016), 236-246.
23. Jin RA, Wang YF, Yu H, Liang X, Cai XJ *. Total laparoscopic left hepatectomy for primary hepatolithiasis: Eight-year experience in a single center. Surgery. 159(3)(2016), 834-841.
24. Chen MY, Lin JW, Zhu HP, Zhang B, Jiang GY, Yan PJ, Cai XJ*. Covered Stents versus Uncovered Stents for Unresectable Malignant Biliary Strictures: A Meta-Analysis. Biomed Res Int. 2016, 6408067.
25. Cai LX, Tong YF, Yu H, Liang X, Liang YL, Cai XJ*. Is Laparoscopic Hepatectomy a Safe, Feasible Procedure in Patients with a Previous Upper Abdominal Surgery? Chin Med J (Engl). 129(4)(2016), 399-404.
26. Zheng X, Feng X, Cai XJ*. Effectiveness and safety of continuous wound infiltration for postoperative pain management after open gastrectomy. World J Gastroenterol. 22(5)(2016), 1902-1910.
27. Liang X , Ying HN, Wang HW, Xu HX, Yu H, Cai LX, Wang YF, Tong YF, Ji L, Luo RJ, Cai XJ*. Enhanced Recovery Program Versus Traditional Care in Laparoscopic Hepatectomy. Medicine. 95(8)(2016), e2835.
28. Hong JJ, Zhang XF, Luo RJ, Cai XJ*. The clinical risk factors associated with postoperative bile leakage after hepatectomy: a meta-analysis. Minerva Med. 107(1)(2016), 39-53.
29. Cai XJ*, Zhao J, Wang YF, Yu H, Liang X, Jin RN, Meng N, Chen J. A Left-Sided, Purely Laparoscopic Approach for Anatomic Caudate Hepatectomy: A Single-Center Experience. J Laparoendosc Adv Surg Tech A. 26(2)(2016), 103-108.
30. Qi XC, Wan YF, Zhan QT, Yang SX, Wang YR, Cai XJ*. Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants. Mamm Genome. 27(1-2)(2016), 1-7.
31. Zhang XF, Liu JH, Liang X, Chen J, Hong JJ, Li LB, He Q, Cai XJ*. History and progression of Fat cadherins in health and disease. Onco Targets Ther. 9(2016), 7337-7343.
32. Feng X, Zhu KL, Liu JH, Chen J, Tang JC, Liang YL, Jin EA, Liang X, Cai XJ*. The evaluative value of Sema3C and MFN2 co-expression detected by immunohistochemistry for prognosis in hepatocellular carcinoma patients after hepatectomy. Onco Targets Ther. 9(2016), 3213-3221.
33. Chen MY, Lin JW, Zhu HP, Zhang B, Jiang GY, Yan PJ, Cai, XJ*. Covered Stents versus Uncovered Stents for Unresectable Malignant Biliary Strictures: A Meta-Analysis. Biomed Res Int. 2016, 1-8.
34. Shi L, Lin H, Li GH, Sun Y, Shen JL, Xu JJ, Lin CY, Yeh SY, Cai XJ*, Chang, CS. Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals. Cancer Lett. 373(1)(2016), 45-56.
35. Song CY, Wang JB, Cai XJ*, Gao L. Synchronous parathyroid carcinoma and papillary thyroid carcinoma: a case study and review of literature. Int J Clin Exp Pathol. 9(1)(2016), 302-309.
36. Cai XJ, Liang Xiao, Yu TN, Liang YL, Jing RN, Jiang WB, Li JB, Ying HN. Liver cirrhosis grading Child-Pugh class B: a Goliath to challenge in laparoscopic liver resection?-prior experience and matched comparisons. Hepatobiliary Surg Nutr. 4(6)(2015), 391-397.
37. Sun J, Shen Q, Lu HQ, Jiang ZN, Xu WX, Feng LF, Li L, Wang X, Cai, XJ*, Jin HC. Oncogenic Ras suppresses ING4-TDG-Fas axis to promote apoptosis resistance. Oncotarget. 6(39)(2015), 41997-42007.
38. Cai XJ*, Ying HN, Yu H, Liang X, Wang YF, Jiang WB, Li JB, Ji L. Blunt Dissection: A Solution to Prevent Bile Duct Injury in Laparoscopic Cholecystectomy. Chin Med J (Engl). 128(23)(2015),3153-3157.
39. Lai HC, Yeh CC, Jeng LB, Huang SF, Liao PY, Lei FJ, Hsu CL, Cai XJ*, Chang CS, Ma WL. Androgen receptor expression decreases recurrence of hepatocellular carcinoma after liver resection. J Gastroenterol Hepatol. 30(2015), 345.
40. Tang JC, Liu JH, Liu XL, Liang X, Cai, XJ*. Effect of fibulin-5 on adhesion, migration and invasion of hepatocellular carcinoma cells via an integrin-dependent mechanism. World J Gastroenterol. 21(39)(2015), 11127-11140.
41. Chen J, Jin RN, Zhao J, Liu JH, Ying HN, Yan H, Zhou SJ, Liang YL, Huang DY, Liang X, Yu H, Lin H, Cai XJ*. Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma. Cancer Lett. 367(1)(2015), 1-11.
42. He ZF, Zhang H, Miao HW, Li ZJ, Zhou JJ, Yan XY, Cai XJ*. 1-o-acetylbritannilactone (ABL) inhibits angiogenesis and lung cancer cell growth through regulating VEGF-Src-FAK signaling. Biochem Biophys Res Commun. 464(2)(2015), 422-427.
43. Cai XJ*, Yu TN, Yu H. Staging Laparoscopy Is Not the Best Option to Identify Unresectable Gallbladder Cancer With 100% of Accuracy. Ann Surg. 262(2)(2015), e57.
44. Shen B, Yu H, Yu TN, Shen JL, Meng N, Cai XJ*. A CD52 antibody impairs mouse-transplanted intestinal tight junctions. J Surg Res. 196(2)(2015), 278-284.
45. Fang YF, Liang X, Jiang WB, Li JB, Xu JF, Cai XJ*. Cyclin B1 Suppresses Colorectal Cancer Invasion and Metastasis by Regulating E-Cadherin. Plos One. 10(5)(2015).
